Zogenix files for $90 million IPO
September 7, 2010 by MassDevice staff
Zogenix Inc. files for a $90 million initial public offering to fund the development of pain medications and a needle-free injector.
Zogenix Inc. is attempting to raise $90 million through an initial public offering.
The San Diego-based company said it plans utilize the new funds to help commercialize its Sumavel DosePro drug-device combination and the clinical advancement of its ZX002 drug in a Securities & Exchange Commission filing.
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
- Raising an early warning in the ICU: T3
- Staff shakeup underway at Russian medical device regulator
- Heart Rhythm Society 2013 Scientific Session wrap-up
- Physician blogger insights on social media
Navigation
NEWS
FDA lowers regulatory bar for ingestible sensors
The FDA lowers the regulatory bar for ingestible event markers, downgrading them from Class II to...
Tryton Medical launches side-branch stent in Europe
Tryton Medical launches its side-branch short stent in Europe after winning CE Mark approval.
Direct Flow Medical wins FDA approval for U.S. trial of new heart valve
Direct Flow Medical wins FDA approval for a U.S. trial of its new transcatheter aortic valve implant...
Thoratec announces FDA approval of HeartMate II pocket controller
The FDA approves Thoratec's pocket controller for its HeartMate II implantable heart pump.
Devon Medical gains extriCARE CE Mark
Devon Medical wins CE Mark approval in the European Union for its portable extriCARE negative...
